Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Welcome and Introduction to Vi3C

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Apr
01
Today In Oncology
Molecular Test Doubles Detection of Bile Duct Cancer
‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?
Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence
Risk of Subsequent Cancer in Solid Organ Transplant Recipients With Pretransplant Cancer History
Elinzanetant May Reduce Side Effects of Endocrine Therapy Among Patients With Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo